Advertisement
Advertisement
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
4.08
USDSponsored
+0.11
+2.77%
Sep 11, 15:57 UTC -4
Closed
After-Market
4.00
-0.08
-1.96%
IRWD Earnings Reports
Positive Surprise Ratio
IRWD beat 21 of 42 last estimates.
50%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$124.00M
/$0.32
Implied change from Q2 26 (Revenue/ EPS)
+9.69%
/+3.23%
Implied change from Q3 25 (Revenue/ EPS)
+1.59%
/+33.33%
Ironwood Pharmaceuticals, Inc. - Class A earnings per share and revenue
On Aug 06, 2026, IRWD reported earnings of 0.31 USD per share (EPS) for Q2 26, missing the estimate of 0.36 USD, resulting in a -14.62% surprise. Revenue reached 113.04 million, compared to an expected 117.14 million, with a -3.50% difference. The market reacted with a +2.65% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.32 USD, with revenue projected to reach 124.00 million USD, implying an increase of 3.23% EPS, and increase of 9.69% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
BioLineRX Ltd
Report Date
Aug 31, 2026 For Q2 26
Estimate
-Actual
-$0.77
Surprise
-
Galmed Pharmaceuticals Ltd.
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.18
Actual
$2.86
Surprise
+189.87%
FAQ
What were Ironwood Pharmaceuticals, Inc. - Class A's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Ironwood Pharmaceuticals, Inc. - Class A reported EPS of $0.31, missing estimates by -14.62%, and revenue of $113.04M, -3.5% below expectations.
How did the market react to Ironwood Pharmaceuticals, Inc. - Class A's Q2 2026 earnings?
The stock price moved up 2.65%, changed from $4.15 before the earnings release to $4.26 the day after.
When is Ironwood Pharmaceuticals, Inc. - Class A expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Ironwood Pharmaceuticals, Inc. - Class A's next earnings report?
Based on 4
analysts, Ironwood Pharmaceuticals, Inc. - Class A is expected to report EPS of $0.32 and revenue of $124.00M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.